TipHub

₹281.65

▲ +9.84 +3.62%

As of 13 Nov 2026 · delayed

NSE Listed

Medicamen Biotech Limited (MEDICAMEQ)

Volume: 11,514Avg Vol 1W: 11,004.6Avg Vol 1M: 15,15652W Range:₹212.4₹447.65
NSE BSE www.medicamen.com AI Report
Key Ratios
Checked just now
Market Cap₹398 Cr
Current Price₹281.65
Previous Close₹271.81
High / Low (52w)₹447.65 / ₹212.4
Volume11,514
Avg Vol (1W)11,004.6
Avg Vol (1M)15,156
Stock P/E36.71
Book Value₹208.66
Dividend Yield34%
ROE411.1%
ROA335.1%
Revenue (TTM)₹169 Cr
Revenue Growth-9.3%
Profit Margin5.51%
Total Debt₹4 Cr
Shares Outstanding1 Cr
Face Value₹10
EPS (TTM)₹7.7
P/B1.35
Debt / Equity0.17
50 DMA₹291.61
200 DMA₹270.13
Day change+3.62%
Price Chart
₹281.65▼ 31.41% · 1Y
₹416₹2203.6L
2025-11-14
2026-11-13

20-day avg volume: 15K shares

Pros
  • Healthy return on equity of 411.1%.
  • Pays a dividend yield of 34.0%.
  • Company is almost debt-free.
  • Revenue grew 12% YoY.
Quarterly Results
MetricJun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹43 Cr₹47 Cr₹47 Cr₹61 Cr₹48 Cr
EBITDA₹3 Cr₹3 Cr₹3 Cr₹4 Cr₹3 Cr
Net Profit₹2 Cr₹3 Cr₹2 Cr₹4 Cr₹2 Cr
EPS1.181.561.213.281.36
Profit & Loss (Annual)
MetricMar 2017Mar 2018Mar 2019Mar 2020
Revenue₹83 Cr₹112 Cr₹123 Cr₹117 Cr
EBITDA₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Net Profit₹5 Cr₹10 Cr₹12 Cr₹12 Cr
EPS————
Balance Sheet
MetricMar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹279 Cr₹295 Cr₹297 Cr₹372 Cr
Total Liabilities₹85 Cr₹88 Cr₹84 Cr₹96 Cr
Equity₹193 Cr₹205 Cr₹212 Cr₹273 Cr
Total Debt₹26 Cr₹31 Cr₹34 Cr₹49 Cr
Cash Flow
MetricMar 2023Mar 2024Mar 2025Mar 2026
Operating₹-6 Cr₹-7 Cr₹-8 Cr₹-33 Cr
Investing₹-6 Cr₹-6 Cr₹-1 Cr₹-3 Cr
Financing₹29 Cr₹6 Cr₹-1 Cr₹64 Cr
Free Cash Flow₹-13 Cr₹-13 Cr₹-10 Cr₹-38 Cr
Shareholding
Promoter 60.32% Institutions 0% Public 39.68%
About Medicamen Biotech Limited

Healthcare · Drug Manufacturers - Specialty & Generic

Medicamen Biotech Limited, a pharmaceutical company, research, develops, manufactures, markets, and sells pharmaceutical formulations in India and internationally. The company provides tablets, capsules, dry syrups, oral liquids, ointments, and other pharmaceutical dosage forms. Its products are used in therapeutic areas comprising cancer care, cardiology, CNS, diabetology, anti-infective, anti-malarials, vitamins and supplements, antibiotics, pain management, and other generics. Medicamen Biotech Limited was incorporated in 1993 and is based in New Delhi, India.

www.medicamen.com ↗
Shareholding Details

As of 2026-09-30

Promoter60.3%
FII—
DII—
Institutions0%
Public39.7%
Promoter Pledge—
No. of Shareholders—
Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Magellanic Cloud LimitedMcon Rasayan India Ltd.Multi Commodity Exchange of India Ltd.Marvel Decor LimitedGlobal Health LimitedMedi Assist Healthcare Services Ltd.Medi-Caps Ltd.Medico Remedies LimitedMedicamen Organics Ltd.Medistep Healthcare Ltd.Medplus Health Services Ltd.Meesho LimitedAll “M” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search